Hindustan Antibiotics

Land parcels of pharma PSUs find no takers, but momentum likely in few mths

In December 2019 the decision was revised to allow sale of land to private entities as well through a competitive bidding process

China crisis, India scouting for APIs a shot in arm for sick pharma PSU

Govt is trying to reduce dependence on China for APIs and develop indigenous sources

Hindustan Antibiotics seeks redemption amid rising anti-China sentiments

The firm is charting a turnaround plan by beginning the manufacturing of key bulk drugs that the government has identified under a production-linked incentive (PLI) scheme

Pharma PSUs likely to sign MoU with LMA for sale of surplus land

The PSUs thus are hopeful that the sale process could now be expedited

Hindustan Antibiotics may not find buyers

With unpaid dues and near zero production, country's first public sector drug unit is in a state of neglect